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Abstract 
Background: To examine demographic and clinical characteristics as potential predictors of change for children and 
youth with emotional disorders treated at two child and adolescent mental health outpatient services (CAMHS) in 
Norway.
Methods: The study was of naturalistic observational type with “treatment as usual” (TAU). The sample consisted 
of 84 children and youth with emotional disorders. The Health of the Nation Outcome Scale (HONOSCA), and the 
Children’s Global Assessment Scale (CGAS) were administered at intake (T0), during the assessment (T1) and approxi-
mately six months after assessment (T2). Change was analysed by means of the linear mixed models procedure.
Results: For the HONOSCA total score, youths with a diagnosis of depression had statistically higher symptom sever-
ity levels at baseline and significantly lower change rates as compared to youths with an anxiety disorder.
Conclusions: The current study adds to the limited knowledge of predictors of rate of change for children and ado-
lescents with emotional disorders treated within CAMHS. Our results point to a special need to improve clinical care 
for depressed children and adolescents. Important limitations comprising the external validity of the study concern 
missing data, a small study sample, and lack of information regarding the content and extent of the service provided.
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Background
Depression and anxiety disorders are among the most 
prevalent problems presented in CAMHS in Norway [7, 
35] and elsewhere [38, 41, 56]. Anxiety and depression 
often occur, both concurrently and sequentially [9, 14, 
15]. The core emotions distinguish depressive disorder 
(depressed mood) and anxiety disorder (anxiety), while 
the secondary symptoms overlap considerably (e.g. dif-
ficulty with sleep, reduced concentration, rumination) 
[59]. Especially between depressive disorder and gener-
alized anxiety disorders [31], and between social pho-
bia and depressive disorders the overlap is considerable. 
Common biological markers as well as common risk 
factors have been described for these disorders. Research 
further suggests that different life events lead to the dif-
ferent disorders and that the prognosis for the two dis-
orders differs [31]. Results from the Bergen child study 
(BCS) in Norway indicated that only 13 % of the group of 
children with anxiety or depressive disorder receive spe-
cialized mental health care [23].
For a better understanding of what kind of treatment is 
effective, it is of importance to identify and understand 
factors influencing treatment response [16, 34, 36]. Such 
knowledge may facilitate the process of targeting the treat-
ment interventions to fit better individual client needs and 
to develop the most effective treatments. In the present 
study we examine potential predictors of rate of change 
[54, p. 137] during CAMHS interventions. Potential pre-
dictors of treatment change are numerous. Characteristics 
of the therapist (e.g. experience, theoretical orientation), 
family context (socioeconomic status, living situation, 
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parental strain), parental context (marital satisfaction, psy-
chopathology), and child characteristics (e.g. gender, age), 
are all potential predictors of treatment change.
Predictors of change have been primarily investigated 
in randomized controlled studies of cognitive-behav-
ioural therapy in research clinics. To date, there is little 
consistent knowledge concerning predictors of change 
in anxiety and depression during and after psychiat-
ric treatment in childhood. In summary, according to 
the majority of studies there is no association between 
demographic factors (gender and age) and change dur-
ing treatment [11, 42]. Secondly, high baseline symp-
tom severity and depression with comorbid anxiety are 
associated with a poorer treatment outcome in several 
studies of primary depression [10–12, 42]. Thirdly, asso-
ciations between general or non-internalizing comorbid-
ity and depression treatment outcome have most often 
been non-significant [42, 45]. Fourthly, the majority of 
findings from the anxiety studies suggests that severity 
and comorbidity do not impact on change during treat-
ment [42, 45], but several studies also indicate that higher 
severity of anxiety and comorbid internalizing (i.e. other 
anxiety or depressive) disorder are predictive of less 
change during treatment [3, 17, 37, 44, 55]. A few studies 
have indicated that social functioning and conflicts may 
impact on change during treatment in depression [20, 28, 
51] and in anxiety disorders [51].
Aims and hypothesis
There is a need for more knowledge regarding fac-
tors influencing change during treatment in outpatient 
CAMHS. The aim of this study was to examine demo-
graphic and clinical characteristics of patients as poten-
tial predictors of rate of change in the clinician-rated 
HONOSCA (total score) and the CGAS, during child and 
adolescent psychiatric outpatient treatment in a natural-
istic sample of patients with anxiety and/or depressive 
disorders (hereafter referred to as emotional disorders). 
In the current study, change during treatment was con-
ceptualized as the average rate of change per month on 
symptomatic level and functional impairment scores. 
Throughout the text, we use the term “rate of change” 
to refer to the observed differences in symptomatic- and 
functional impairment level during the period of service 
provision. When referring to other treatment outcome 
studies we use the general term “change” to conceptual-
ize any approach to the definition of change during treat-
ment. The following research question was addressed:
1. Predictors of rate of change over time:
a. Does any of the pre-treatment demographic or 
clinical characteristics predict rate of change 
over time in HoNOSCA and CGAS? The char-
acteristics tested were age, gender, baseline 
symptom severity or functional impairment, 
type of emotional disorder, comorbidity, proso-
cial characteristics and problem with peers. We 
also examined whether there were differences 
between the two clinics in HoNOSCA and 
CGAS rates of change.
Methods
Subjects and setting
The present study is part of a larger multicenter study 
including seven child and adolescent mental health clin-
ics (CAMHS) in the Northern and the South-eastern 
parts of Norway. The multi-center study was a natural-
istic observational study where data from clinical instru-
ments were collected as part of ordinary clinical practice. 
Since treatment practice was not changed as a result of 
the ongoing observational study, the treatment given can 
be classified as “treatment as usual” (TAU). The content, 
type and the extent of the treatment provided were not 
recorded in this study. Clinicians’ verbal accounts in ret-
rospect of what constituted “treatment as usual” indicate 
that no particular therapeutic or theoretical approach 
took precedence at the clinics, but where chosen accord-
ing to the individual clinicians’ competence. Both cogni-
tive-behavioural- and psychodynamic approaches were 
used and both individual and family-based interventions 
were offered. For depression and anxiety disorders, medi-
cal treatment was not first line treatment, but was in a 
few cases offered as additional treatment.
Among the 320 clients eligible for this part of the multi-
centres study, only 276 patients had data for two or more 
measurement occasions. In the present study, a subsam-
ple of 84 patients with emotional disorders treated at two 
CAMHS in the north of Norway was the target group. 
The two centres, CAMHS Alta (n  =  56) and CAMHS 
Silsand (n =  28), were the only clinics within the multi-
centre study collecting follow-up data. The two centres 
had similar population composite with both a rural and 
semirural population base. Based on accounts from clini-
cal staff, there are no obvious overall differences in the 
type of treatment offered at the two centres. Characteris-
tics of the CAMHS Alta, the CAMHS Silsand sample, and 
the multicentre sample are presented in Additional file 1: 
Table S1, whereas characteristics of the study sample are 
presented in Table 1. The study sample consists of 56 girls 
(66.7 %) and 28 boys (33.3 %). The mean age of the sam-
ple was 12.49  years at intake, and the girls (M =  13.21, 
SD = 2.65) were significantly older (t (82) = −3.24, p < .01) 
than the boys (M  =  11.04, SD  =  3.38). Twenty-seven 
patients (32.2 %) were assessed as depressed (4 boys and 23 
girls), 38 patients (45.2 %) as having one or more anxiety 
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disorders (18 boys and 20 girls), and 19 patients (22.6 %) 
were assessed as having both depressive and anxiety prob-
lems (6 boys and 13 girls). The children and adolescents 
included in this study will in the following be referred to as 
“children”. A follow-up (T2) assessment was not completed 
by the clinicians for 32.1 % (n = 27) of the sample for the 
HONOSCA and 38.1 % (n = 32) for the CGAS. The rea-
son for non-completion is unknown. The group of patients 
without follow-up data was not different from the rest of 
the sample as regards gender composition, mean age, age 
grouping and type of emotional disorder (depression, anxi-
ety or mixed). Test statistics for comparison of the groups 
are presented in Additional file 1: Tables S2, S3.
Procedure
In this multi-centre study, all children and youths 
between the ages of 5 and 18 referred to the clin-
ics between 2002 and 2005 were asked to participate. 
The only exclusion criteria were acute referral and 
age <5 years. Refusal to participate in the study did not 
affect the service offered, and non-participants were 
assessed and treated by the same procedures as study 
participants. Measures by means of questionnaires 
were repeated on three occasions. The clinician rated 
HONOSCA and the CGAS were administered at intake 
(T0), during assessment/treatment (T1) and approxi-
mately 6  months after the assessment (T2). At T1, The 
Kiddie-SADS PL, a semi-structured diagnostic inter-
view (age range 6–18 years), was used to aid diagnostic 
evaluation [1, 30], and diagnosis. Due to the problem 
of incomplete data, we had to rely on different selec-
tion procedures to identify the greatest number of rel-
evant cases. First, we used the Kiddie-SADS interview to 
identify children and youth that fulfilled the criteria for 
a diagnosis of unipolar depression and/or a diagnosis of 
one or several anxiety disorder (n = 57). Two raters, Toril 
Sørheim Nilsen and Siv Kvernmo, rated all the inter-
views independently. Bjørn Helge Handegård, calculated 
the inter-rater agreement. The Gwet’s AC2 per disorder 
is presented in Additional file 1: Table S4. Furthermore, 
cases with disparate ratings were discussed and consen-
sus based diagnoses were set. Finally, cases with miss-
ing data for the Kiddie-SADS, but with a registered axis 
1 diagnosis of depression and/or anxiety, were selected 
(n = 27). In the clinics, diagnoses were consensus based 
and evaluated by a specialist in clinical psychology or 
psychiatry (Figs. 1, 2).
The study had been approved by the Regional Commit-
tee for Medical and Health Research Ethics of Northern 
Norway.




Gender  % (n)
 Male 32.9 (27) 33.8 (27)
 Female 67.1 (55) 66.3 (53)
Age (Mean/SD) 12.6 (2.99) 12.51 (2.98)
Age group  % (n)
 0–6 years 2.4 (2) 2.5 (2)
 7–12 years 40.2 (33) 41.3 (33)
 13–18 years 57.3 (47) 56.3 (45)
Emotional disorders  % (n)
 Anxiety 46.3 (38) 46.3 (37)
 Depression 32.9 (27) 32.5 (26)
 Mixed anx/depr 20.7 (17) 21.3 (17)
Duration of problems  % (n)
 Less than a month – –
 1–5 months 8.8 (7) 8.5 (7)
 6–12 months 10.0 (8) 9.8 (8)
 More than 12 months 42.5 (34) 42.7 (35)
 Missing 38.8 (31) 39.0 (32)
Family arrangement
 Both parents 30.5 (25) 30 (24)
 Part time mum/dad 7.3 (5) 7.5 (6)
 Either mum/dad 34.1 (28) 35 (28)
 Parent/stepparent 8.5 (7) 8.8 (7)
 Grandpar/relatives – 1.3 (1)
 Fosterhome 3.7 (3) 3.8 (3)
 Institution 4.9 (4) 3.8 (3)
 Alone 1 (1.2) 1.3 (1)
 Other 1 (1.2) 1.3 (1)
Ethnicity (mother)
 Norwegian 90.2 (74) 90 (72)
 European 1.2 (1) 1.3 (1)
 Missing 8.5 (7) 8.8 (7)
Ethnicity (father)
 Norwegian 85.4 (70) 85 (68)
 European 1.2 (1) 1.3 (1)
 Sami 1.2 (1) 1.3 (1)
 African 1.2 (1) 1.3 (1)
 Missing 11 (9) 11.3 (9)
Repeated measurement
 All assessments 46.3 (38) 61.3 (49)
 T0–T1 20.7 (17) 17.5 (14)
 T1–T2 6.1 (5) 7.5 (6)
 T0–T2 8.5 (7) 3.8 (3)
 One assessment only 18.4 (15) 9.9 (8)
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Measures
Diagnostic interview
The Schedule for Affective Disorders and Schizophrenia 
for School-Age Children-Present and Lifetime version 
(K-SADS-PL) was used as the diagnostic interview dur-
ing assessment [1, 30]. The interview provides DSM-IV 
diagnoses of a wide range of psychiatric disorders. First, 
the clinician conducted the screening interview with a 
primary caregiver and the child/adolescent. Problem 
areas being discovered during the screening were further 
assessed through targeted supplements. For our sample 
the most common supplements were: 1. Affective disor-
ders (n =  29), and/or supplement 3. Anxiety disorders 
(n =  34). Other supplements conducted in this sample 
were: Supplement 4. Behavioural disorders (n = 18), Sup-
plement 5. Drug abuse and other disorders (n = 5), and 
Supplement 2. Psychotic disorders (n  =  2). The inter-
views were all conducted by clinicians trained and expe-
rienced with the Kiddie SADS. No further interrater 
reliability tests were done in the clinics.
The Health of the Nation Outcome Scale (HONOSCA)
The HONOSCA is a 15-item clinician-rated measure of 
mental health symptoms in children and adolescents. The 
HONOSCA items are scored on a 5-point scale from 0 
(no problem) to 4 (severe to very severe problems) with 
a maximum total score of 52. The Norwegian version of 
HoNOSCA has been found to have good psychometric 
properties, with good inter-rater reliability, good sensitiv-
ity to change, and good concurrent and criterion-related 
validity [49]. The HONOSCA have also been found to be 
sensitive to change in clinical populations [4, 5, 18, 19, 24, 
All participants  
N = 276 
other 
N = 192 
69.6 % 
T0 Intake 
N = 180 
93.8 % 
T1 Assessment  
N = 115 
59.9 % 
T2 Follow-up 
N = 92 
47.9 % 
emotional disorders 
N = 84 
30.4 % 
T0 Intake 
N = 74 
88.1 % 
T1 Assessment  
N =  70 
83.33 % 
T2 Follow-up  
N =  57 
67.9 % 
Fig. 1 Flowchart of participants: Clinician rated HoNOSCA
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T1 Assessment  
N =  109 
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N =  95 
49.5 %  
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N = 84 
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T0 Intake 
N = 72 
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T1 Assessment  
N =  63  
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T2 Follow-up  
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Fig. 2 Flowchart of participants: Clinician rated CGAS
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32, 33, 47]. In the present study, total score changes were 
evaluated. Cronbach’s α for the HONOSCA total score at 
intake was .52 for the current sample. The HONOSCA 
total score has proven as a good quantitative measure of 
clinical severity [5, 19] and correlates well with the CGAS 
[38, 60].
The Children’s Global Assessment Scale (CGAS)
The CGAS [52] is a clinician-rated score in the range 
from 0 (needs constant supervision) to 100 (superior 
functioning in all areas). The CGAS is being extensively 
used as a measure of change in global functioning. The 
psychometric properties of the CGAS show moderate 
reliability and validity [38, 39, 48, 53]. The CGAS has 
been used as one “gold standard” for psychosocial func-
tioning when validating other instruments [50]. Several 
recent large-scale outcome studies, both naturalistic 
studies and randomized controlled trials, have included 
change in the CGAS as one outcome measure [38, 60]. 
The Norwegian version of the CGAS is currently being 
evaluated for its psychometric properties.
Predictor variables
Potential predictors were demographic and clini-
cal characteristics recorded at baseline or during the 
assessment. Clinic was coded as 0 (CAMHS Alta) and 
1 (CAMHS Silsand). Gender was coded as 0 (male) and 
1 (female). Age at intake was centred, and the mean age 
for the sample of patients with emotional disorders was 
12.49 years (SD = 3.07, min–max 4–18). Baseline sever-
ity: The HONOSCA total score at baseline was tested as 
a continuous predictor of change over time in the CGAS. 
Baseline functioning: Baseline CGAS—scores was tested 
as a continuous predictor of change in the HONOSCA 
total score. Comorbidity as a covariate was assessed by 
comorbid disorders through the Kiddie-SADS interview 
dichotomous variable (0  no comorbid disorder, 1  one 
or more comorbid disorders). The strenghts and dif-
ficulties questionnaire (SDQ) prosocial scale (self- and 
mother reported) was used to assess social competence, 
and was coded as a continuous variable with a scale from 
0 through 10. The SDQ peer problem scale (self- and 
mother reported) was coded as a continuous variable 
with a scale from 0 through 10.
Statistical analysis
All statistical analyses were performed using SPSS ver-
sion 22.0. Longitudinal multilevel analysis, also known 
as the mixed models approach, was used in this study. 
When evaluating the effects of predictors of rate change 
and of baseline symptom severity and functional impair-
ment we assessed the random intercept and the random 
slope to see whether individual variances in initial status 
or rate of change were statistically significant, and thus 
whether there were variability that could be explained 
by potential predictors. Potential predictors were tested 
individually as covariates in the fixed effects part of the 
model. We evaluated the interaction effect between the 
variables with time onto the dependent variables.
Multilevel‑model‑based fit indices and total variability 
explained
The likelihood ratio test [46] was used to assess the 
improvement in fit from the random intercept model to 
the random intercept and random slope model. Singer 
and Willett [52–54] [pp. 102–103] account of the pseudo-
R2 statistic was used. We calculated the pseudo-R2 statis-
tic of the total outcome variability that was explained by 
the predictors in the model, and we assessed change in 
the pseudo-R2 statistic when adding a predictor. Accord-
ing to Singer and Willett [54] this pseudo-R2 must be 
interpreted with caution, since total outcome variation is 
partitioned into several variance components.
Results
Results of the mixed models analysis with the 
HONOSCA and the CGAS as dependent variables are 
presented in Tables 2 and 3, respectively. Explanations of 
the tables’ parameters in relation to the different predic-
tor variables are presented in the supplemental material. 
The results regarding the average rate of change for the 
HONOSCA and the CGAS (the fixed effects of time) has 
been presented in prior work [43] and we only present 
the main-findings for the clinician-reported measures 
here. First, the average change rates per month (fixed 
slopes) indicate statistically significant improvement 
in total severity (HONOSCA: β01  =  −.52, SE  =  0.06, 
p  <  .001) and in psychosocial functioning (CGAS: 
β01 = .98, SE = .17, p < .001). Looking at the effect sizes, 
the pseudo-R2 showed small to moderate associations 
between predicted and observed scores with 18  % of 
change in the HONOSCA total score and 12  % of the 
change in the CGAS being associated with linear time. 
For the clinician rated measures, the change rate during 
the active assessment/treatment period (T1–T2) seem 
to be larger than the average change rates of the waitlist 
periode (T0–T1). Finally, from the perspective of clini-
cally significant change, only a small proportion of sub-
jects could be classified as recovered and/or improved. 
For the majority of subjects, the degree of change was 
uncertain.
Random effects
Results for the random effects part of the model are not 
presented in the Tables, but will be shortly presented 
here. Residual variation on level 1 was highly significant 
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for all models, indicating the potential to include time-
varying predictors. The random intercept was also sig-
nificant in all models, with a few exceptions. The random 
slope and the intercept-slope covariance were not statis-
tically significant in any models, with a few exceptions.
Clinic
Results of the mixed models analysis with clinic as a 
covariate in the model showed that for the HONOSCA 
total score there were no significant differences in 
total severity at baseline or in rate of change over time 
between the CAMHS Alta and the CAMHS Silsand sam-
ples. Results for the CGAS showed statistically significant 
differences between the clinics in baseline predicted 
mean scores (CAMHS Alta: β01  =  66.78; CAMHS Sil-
sand: β01 = 57.76; t = 3.44, p < .01) and in rate of change 
per month (CAMHS Alta: β11 =  .72, SE =  .44; CAMHS 
Silsand: β11 = 1.73, t = −2,31; p < .05).
Predictors of change over time in the HONOSCA and CGAS
The random slopes were not statistically significant for 
any model, which implies little between-patient variabil-
ity in the development over time in the HONOSCA and 
CGAS. The likelihood ratio test showed a statistically sig-
nificant improvement in fit of the model with the CGAS 
as change measure (χ2 (2) = 35.81, p <  .01), but not for 
Table 2 Longitudinal analysis of  the HONOSCA total score with  demographic and  clinical factors as  covariates, 
with Pseudo-R2 (total variability explained)
* p < .05, ** p < .01, *** p < .001 table parameters in Table 2 through 9 are explained in Additional file 1
Fixed effects Pseudo‑R2
Variable Intercept Time (month) Predictor Time X predictor
Predictor variable
 No predictor 13.50 (.58)*** −.52 (.06)*** – – .18
 Gender 13.43 (.71)*** −.58 (.08)*** 0.22 (1.24) 0.16 (.13) .19
 Age 13.35* (.58)*** −.52 (.06)*** 0.27 (.20) −.01 (.02) .19
 CGAS (baseline) 16.26 (4.90)** −1.46 (.72)* −0.05 (.07) .01 (.01) .15
 Depression vs anxiety 12.24 (.83)*** −.40 (.08)*** 2.63 (1.29)* −.29 (.13)* .20
 Depression vs mixed 14.12 (1.15)*** −.57 (.14)*** 0.74 (1.48) −.12 (.20) .26
 Anxiety vs mixed 14.16 (1.29)*** −.57 (.13)*** −1.92 (1.55) .17 (.15) .15
 Comorbidity 12.48 (.81)*** −.56 (.09)*** 1.88 (1.05) .08 (.11) .25
SDQ scores at baseline
 Prosocial scale (mother-report) 16.90 (2.44)*** −.39 (.30) −.54 (.30) −.01 (.04) .19
 Peerproblems (mother-report) 10.68 (.87)*** −.47 (.10)*** .71 (.26)** .00003 (.03) .24
Table 3 Longitudinal analysis of  the CGAS score with  demographic and  clinical factors as  covariates, with  Pseudo-R2 
(total variability explained)
* p < .05, ** p < .01, *** p < .001
Variable Fixed effects Pseudo-R2
Intercept Time (month) Predictor Time X predictor
Predictor variable
 No predictor 64.03 (1.32)*** .98 (.17)*** – – .12
 Gender 65.21 (1.46)*** 1.04 (.20)*** −0.3.78 (2.56) −0.16 (.35) .16
 Age 64.12 (1.35)*** .95 (.17)*** −0.05 (.45) −0.06 (.06) .12
 HoNOSCA (baseline) 70.29 (5.14)*** .24 (.91) −0.33 (.38) 0.06 (.07) .10
 Depression vs anxiety 64.58 (1.98)*** .86 (.24)** −1.16 (3.06) 0.35 (.41) .14
 Depression vs mixed 63.48 (2.74)*** .96 (.32)** 0.001 (3.51) 0.15 (.32) .16
 Anxiety vs mixed 63.92 (2.85)*** .89 (.40)* 0.66 (3.46) −0.03 (.48) .10
 Comorbidity 67.14 (1.88)*** .84 (.24)** −4.94 (2.47)* 0.06 (.31) .15
SDQ scores at baseline
 Prosocial scale (mother-report) 56.71 (5.42)*** .90 (.83) 1.11 (.67) −0.003 (.10) .14
 Peerproblems (mother-report) 68.18 (1.96)*** .82 (.28)** −0.97 (.58) 0.02 (.08) .13
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the HONOSCA total score: (χ2 (2)  =  1.57, p  =  ns). 
Despite this, we chose to explore potential predictors of 
rate of change in the HONOSCA, as well.
Results of the mixed models analysis with the 
HONOSCA as the dependent variable are presented in 
Table  2. Individuals with a diagnosis of depression had 
lower rates of change than individuals with a diagnosis 
of anxiety (β01 = −.29, SE = .13, p < .05). Also, individu-
als with a diagnosis of depression had significantly higher 
baseline scores when compared to individuals with anxi-
ety disorders (β01 = 2.63, SE = 1.29, p < .05). The pseudo-
R2 statistics of total variability explained, ranged from 
15  % (the model with baseline CGAS as predictors) to 
26 % (diagnosis: depression vs mixed) in the model with 
the HONOSCA total score as the dependent variable. 
The pseudo-R2 statistics increased from 18  % (model 
with no predictor) to 26  % in the model with diagnosis 
(depression vs mixed) as a predictor.
Results of the mixed models analysis with the CGAS 
as the dependent variable are presented in Table  3. 
None of the tested variables were significant predic-
tors of change over time in the CGAS. The model with 
no predictor explained 12  % of the total variability. The 
pseudo-R2 statistics of total variability explained with the 
CGAS score as the dependent variable, ranged from 10 % 
(baseline HoNOSCA) to 30  % (self-reported prosocial 
characteristics).
Discussion
To sum up the main findings of this study: firstly, there 
were statistically significant differences between the clin-
ics in the ratings of functional impairment at baseline and 
in the rate of change per month. Children in the CAMHS 
Silsand sample had significantly higher CGAS scores at 
baseline and a significantly higher rate of change as com-
pared to the CAMHS Alta sample. Secondly, children 
with a diagnosis of depression had statistically higher 
symptom severity levels at baseline, and significantly 
lower rates of change in symptom level as compared to 
children with an anxiety disorder. The remaining vari-
ables were not statistically significant predictors of rate 
of change in clinician-reported total severity. Among the 
variables tested here, none were significant predictors of 
rate of change in functional impairment. The main find-
ings listed above will be further discussed.
The patient group at CAMHS Silsand had lower ini-
tial CGAS, and a higher CGAS rate of change than the 
CAMHS Alta patient group. On the other hand the 
clinics did not differ as regards to the corresponding 
HONOSCA scores. The finding may reflect actual differ-
ences between the two clinics in the impact of problems 
for their respective patient groups, and also a difference 
in the rate of change for the samples of their patients. 
The finding may also reflect what is known as regression 
toward the mean (RTM), the tendency for high intitial 
scores to follow a reductionist path and to be closer to 
the mean at follow-up [29]. Differences between the clin-
ics may also reflect local differences at the two clinics in 
how the CGAS scale is implemented and scored rather 
than an actual difference between baseline levels and 
rate of change of the patient groups in the two clinics. 
The interrater reliability of the HoNOSCA (ICC =  .84) 
has been found to be significantly higher than the CGAS 
(ICC = .61) in a large international study [22].
Children with a diagnosis of depression were rated by 
clinicians as having higher levels of symptoms at base-
line and as experiencing less change, when compared to 
children with an anxiety diagnosis. This finding is in line 
with research showing that anxiety disordered youths are 
more likely than depressive youths to recover if treated. 
A meta-analysis of cognitive-behavioural therapy (CBT) 
for youth depression show remission rates of 48  % for 
CBT and 34  % to placebo [57], while remission rates of 
CBT for youths with an anxiety disorder were 57  % for 
CBT and 35 % for placebo [8, 27], respectively. Another 
meta-analysis of psychotherapy for anxiety disorders 
based on 24 randomized controlled trials (all CBT treat-
ment) found a recovery rate of 68.9 %, and an effect size 
of .82 [26]. A review of the current treatment of pediatric 
depression (both psychotherapy and pharmacotherapy) 
estimated remission rates of depression to be 60 % within 
6 months [40]. A meta-analysis of the selective re-uptake 
inhibitor (SSRI) fluoxetine [6], showed a response rate of 
61 % for depressed youth (50 % response to placebo) and 
69  % response rate for anxiety disordered youth (39  % 
response to placebo).
Clinician-rated functional impairment at baseline and 
rate of change, were not different between depressed 
as compared to youths with an anxiety disorder. Thus, 
depressed and anxiety disordered children were assessed 
as equally impaired with regards to psychosocial func-
tioning at baseline. In a large-scale study of psychiatric 
treatment outcomes in CAMHS in Stockholm, Sweden, 
both baseline and change scores of the CGAS for depres-
sive and anxiety-disordered youth were comparable with 
our finding [38].
None of the demographic pre-treatment variables 
emerged as significant predictors of rate of change in 
clinician-rated measures. Thus, gender and age did not 
impact on the rate of change. One plausible interpreta-
tion of this finding may be that the outpatient service 
provided, functioned equally well for both genders and 
for different age groups within this sample of patients. 
The apparent lack of association between demographic 
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factors, such as age and gender, and change during treat-
ment, has been a consistent finding in a meta-analysis 
of depression [58] and in literature reviews and studies 
addressing predictors of change in treatment studies of 
depression or anxiety disorders [2, 11, 13, 25, 42]. Thus, 
one of the most consistent findings regarding predictors 
of change is that age and gender do not seem to impact 
on change rates or rates of remission.
Limitations
This study has several limitations. Firstly, as in many 
naturalistic observational studies, the problem of miss-
ing data could have influenced our results. By using the 
Mixed Models approach, some of the problems with 
missing data were accounted for since this method allows 
for the inclusion of subjects with missing data. Miss-
ing data includes both missing information for vari-
ables tested as predictors, and also the reduction of the 
number of respondents from T0 through T1 to T2. This 
may raise questions about the representativeness of the 
results.
Secondly, a further limitation was the low number of 
clients in this study, and statistical analyses performed 
on small samples may partly explain the lack of effects 
in our study. The multi-centre CAMHS North study was 
not originally designed to examine predictors and mod-
erators of change. In the project plan 300–500 clients 
were expected to be included in the study, and thus the 
study was originally powered to examine mechanisms of 
change. As in many naturalistic observation studies the 
problem of missing data for repeated measurement was 
considerable. Among the 320 clients eligible for this part 
of the multi-centre study, only 276 patients had data for 
two or more measurement occasions. Among the 276, 
only 190 had available data for the diagnostic interview 
Kiddie-SADS. Since the research questions targeted 
interaction effects, and the testing of predictors of rate 
of change, our sample of 84 patients may have been too 
small to detect small and intermediate effects. Corre-
lations between predictors and outcomes are often of 
small to moderate magnitude, and thus large samples are 
needed to achieve sufficient power (n > 200 if r = .2 and 
power =  .8 in correlational analyses) [21]. Also, some of 
the clinical characteristics tested as potential predictors 
should preferably have been tested with more refined cat-
egories (e.g. type of comorbid disorder), but due to few 
clients in most subcategories we decided to dichotomize 
these variables.
A third limitation, which may compromise the external 
validity of the results of this study, is the lack of some rel-
evant information about the service provided. Such infor-
mation could be about type of interventions, number of 
sessions, clinician’s competence and overall caseload, and 
reasons for dropouts. This compromises the opportunity 
to correct for potentially important characteristics with 
the service that could have impacted on the results. Fur-
ther, in this study we included potential predictor vari-
ables that were available within this multicentre study. 
Many potential predictors of change were not available 
for assessment in this study.
On the other hand, one advantage of the present study 
is that it was carried out in a naturalistic setting without 
exclusion criteria, except for age <5 years and acute refer-
ral. We could only find few studies which report findings 
regarding predictors of change in CAMHS outpatient 
settings. Another advantage was the evaluation of predic-
tors of rate of change over time in both symptom sever-
ity and functional impairment. In addition, we assessed 
the impact of multiple potential predictors, both demo-
graphic and clinical.
Implications and recommendations
The results of the current study have implications for 
both clinical practice and research in clinical settings. 
Routinely collecting data about the rate of change in 
patients is an important first step in order to identify for 
whom the treatment works or not. Our results are in line 
with other clinical studies that imply the need to improve 
clinical care and treatment, especially for depressed 
children and adolescent. It is important to note that the 
apparently worse prognosis for depressed patients as 
compared with anxiety disordered patients, both in our 
study and other clinical studies, may be partly due to dif-
ferent mechanisms within the two conditions other than 
the services provided. The centres may benefit from a 
good implementation plan including training and contin-
ued monitoring for mental health professionals.
Regarding implications for research in clinical settings, 
we have several recommendations for similar future 
studies in naturalistic settings. The issue of missing data 
and of accomplishing complete datasets for clinical and 
follow-up data is a recurrent issue in service research [see 
e.g. 2, pp. 45–46]. We became aware of the importance of 
having administrative resources to monitor the data col-
lection process. In this multicentre study, the one clinic 
(CAMHS Alta) with such a resource also had more com-
plete data. The lack of information about both the extent 
and content of the service provided in the current study, 
limits the generalizability of results and also the clini-
cal implications of the information that can be gained 
from this particular service setting. Thus, we will stress 
the importance of having staff monitoring the ongoing 
collection of service data to ensure the registration of 
important service information.
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Conclusions
The current study adds to the limited knowledge of pre-
dictors of rate of change and predictors of baseline symp-
tom severity and functional impairment for children 
and adolescents with emotional disorders treated within 
CAMHS. Naturally, the results need to be replicated in 
future studies. There is a great need of well-planned, and 
carefully monitored studies in naturalistic settings to 
address the research questions raised here. The results 
presented here point to a special need to improve clinical 
care for depressed children and adolescents.
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